Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure

Clinical Nutrition

Volumn 29, Issue 2, 2010, Pages 235-242

  Picot, Denis ^a   Garin, Laurence ^a   Trivin, Florence ^a   Kossovsky, Michel P ^b   Darmaun, Dominique ^c,d   Thibault, Ronan ^c,d  

^a Clinique Saint Yves   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c CRNH AUVERGNE   (France)

^d Universite de Nantes   (France)

Author keywords

Chyme reinfusion; Citrulline; Intestinal failure; Short bowel syndrome

Indexed keywords

CITRULLINE; NITROGEN;

ACUTE INTESTINE FAILURE; ADOLESCENT; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROPATHY; ENTEROSTOMY; FEMALE; HUMAN; INFUSION; INTESTINE RESECTION; LIPID ABSORPTION; MALE; PARENTERAL NUTRITION; SMALL INTESTINE ABSORPTION; THERAPY EFFECT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CITRULLINE; ENTERAL NUTRITION; ENTEROCYTES; ENTEROSTOMY; FEMALE; GASTROINTESTINAL CONTENTS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL DISEASES; INTESTINE, SMALL; MALE; MIDDLE AGED; NUTRITIONAL STATUS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77950300310     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.08.010     Document Type: Article

References (29)

1. DiBaise J.K., Young R.J., Vanderhoof J.A. Intestinal rehabilitation and the short bowel syndrome: part 1. Am J Gastroenterol 2004, 99:1386-1395.
2. Fleming C.R., Remington M. Intestinal failure. Nutrition and the surgical patient: clinical surgery international 1981, 219-235. Churchill Livingstone, Edinburgh. G.I. Hill (Ed.).
3. Messing B., Crenn P., Beau P., Boutron-Ruault M.C., Rambaud J.C., Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999, 117:1043-1050.
4. O'Keefe S.J., Buchman A.L., Fishbein T.M., Jeejeebhoy K.N., Jeppesen P.B., Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006, 4:6-10.
5. Jeppesen P.B., Mortensen P.B. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut 2000, 46:701-706.
6. Smyddi F.G., Gregory S.D., Smith I.B., Goligher J.C. Faecal loss of fluid, electrolytes and nitrogen in colitis before and after ileostomy. Lancet 1960, 1:14-19.
7. O'Keefe S.J., Burnes J.U., Thompson R.L. Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. J Parenter Enteral Nutr 1994, 18:256-263.
8. Lévy E., Palmer D.L., Frileux P., Parc R., Huguet C., Loygue J. Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel. A clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg 1983, 198:596-600.
9. Calicis B., Parc Y., Caplin S., Frileux P., Dehni N., Ollivier J.M., et al. Treatment of postoperative peritonitis of small-bowel origin with continuous enteral nutrition and succus entericus reinfusion. Arch Surg 2002, 137:296-300.
10. Frileux P., Attal E., Sarkis R., Parc R. Anastomotic dehiscence and severe peritonitis. Infection 1999, 27:67-70.
11. Crenn P., Coudray-Lucas C., Thuillier F., Cynober L., Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000, 119:1496-1505.
12. Crenn P., Messing B., Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 2008, 27:328-339.
13. Teubner A., Morrison K., Ravishankar H.R., Anderson I.D., Scott N.A., Carlson G.L. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 2004, 91:625-631.
14. Nightindale J.M.D., Bartram C.I., Lennard-Jones J.E. Length of residual small bowel after partial resection: correlation between radiographic and surgical measurements. Gastrointest Radiol 1991, 16:305-306.
15. Buzby G.P., Williford W.O., Peterson O.L., Crosby L.O., Page C.P., Reinhardt G.F., et al. A randomised clinical trial of total parenteral nutrition in malnourished surgical patients: the rationale and impact of previous clinical trials and pilot study on protocol design. Am J Clin Nutr 1988, 47(2 Suppl.):357-365.
16. Curis E., Crenn P., Cynober L. Citrulline and the gut. Curr Opin Clin Nutr Metab Care 2007, 10:620-626.
17. Moinard C., Cynober L. Citrulline: a new player in the control of nitrogen homeostasis. J Nutr 2007, 137(Suppl.):S1621-S1625.
18. van de Poll M.C., Lighthart-Melis G.C., Boelens P.G., Deutz N.E., van Leeuwen P.A., Dejong C.H. Intestinal and hepatic metabolism of glutamine and citrulline in humans. J Physiol 2007, 581:819-827.
19. Papadia C., Sherwood R.A., Kalantzis C., Wallis K., Volta U., Fiorini E., et al. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol 2007, 102:1474-1482.
20. Rhoads J.M., Plunkett E., Galanko J., Lichtman S., Taylor L., Maynor A., et al. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr 2005, 146:542-547.
21. Crenn P., Vahedi K., Lavergne-Slove A., Cynober L., Matuchansky C., Messing B. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003, 124:1210-1219.
22. Lutgens L.C., Blijlevens N.M., Deutz N.E., Donnelly J.P., Lambin P., de Pauw B.E. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability test. Cancer 2005, 103:191-199.
23. Derikx J.P., Blijlevens N.M., Donnely J.P., Fujii H., Kanda T., van Bijnen A.A., et al. Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. Ann Oncol 2009, 20:337-342.
24. David A.I., Selvaggi G., Ruiz P., Gaynor J.J., Tryphonopoulos P., Kleiner G.I., et al. Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation. Transplantation 2007, 84:1077-1081.
25. Peters J.H., Mulder C.J., van Bodegraven A.A., Ziegler T.R., Luo M. Letter to the editor. J Parenter Enteral Nutr 2008, 32:288-289.
26. Peters J.H., Wierdsma N.J., Teerlink T., van Leeuwen P.A., Mulder C.J., van Bodegraven A.A. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity. Am J Gastroenterol 2007, 102:2814-2819.
27. Luo M., Fernández-Estívariz C., Manatunga A.K., Bazargan N., Gu L.H., Jones D.P., et al. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome?. J Parenter Enteral Nutr 2007, 31:1-7.
28. Ceballos I., Chauveau P., Guerin V., Bardet J., Parvy P., Kamoun P., et al. Early alterations of plasma free amino acids in chronic renal failure. Clin Chim Acta 1990, 188:101-108.
29. 15N]glutamine into citrulline and arginine in humans. J Parenter Enteral Nutr 2007, 31:343-350.